Systematic review of statistical methods used in molecular marker studies in cancer.

Systematic review of statistical methods used in molecular marker studies in cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Systematic review of statistical methods used in molecular marker studies in cancer. Abstract Text:

BACKGROUND.: There is wide interest in the use of molecular markers for the early detection of cancer, the prediction of disease outcome, and the selection of patients for chemotherapy. Despite significant and increasing research activity, to the authors' knowledge only a small number of molecular markers have been successfully integrated into clinical practice. In the current study, the experimental designs and statistical methods used in contemporary molecular marker studies are reviewed, particularly with respect to whether these evaluated a marker's clinical value. METHODS.: MEDLINE was searched for studies that analyzed an association between a cancer outcome and a marker involving chemical analysis of body fluid or tissue. For each article, data were extracted regarding patients, markers, type of statistical analysis, and principal results. RESULTS.: The 129 articles eligible for analysis included a very large variety of molecular markers; the total number of markers was larger than the number of articles. Only a minority of articles (47 articles; 36%) incorporated multivariate modeling in which the marker was added to standard clinical variables, and only a very small minority had any measure of predictive accuracy (14 articles; 11%). No article used decision analytic methods or experimentally evaluated the clinical value of a marker. Correction for overfit was also rare (3 articles). CONCLUSIONS.: Statistical methods in molecular marker research have not focused on the clinical value of a marker. Attention to sound statistical practice, in particular the use of statistical approaches that provide clinically relevant information, will help maximize the promise of molecular markers for care of the cancer patient. Cancer 2008. (c) 2008 American Cancer Society.

Systematic review of statistical methods used in molecular marker studies in cancer. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Systematic review of statistical methods used in molecular marker studies in cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer

VOLUME: 112

Page Numbers: 1862-8

Journal Abbreviation: Cancer

ISSN: 0008-543X

DAY: 15

MONTH: Apr

YEAR: 2008

Systematic review of statistical methods used in molecular marker studies in cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 374236

Systematic review of statistical methods used in molecular marker studies in cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Systematic review of statistical methods used in molecular marker studies in cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Systematic review of statistical methods used in molecular marker studies in cancer.

AFFILIATION: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York City, New York.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Systematic review of statistical methods used in molecular marker studies in cancer Related Publications

• A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
• A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy.
• An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.
• Angiographic confirmation of normal pleural thickness in right-upper-lobe collapse.
• Backward "displacement" of the spinolaminal line at C2: a normal variation.
• Child abuse and neglect: Perspective from King Faisal Specialist Hospital and Research Centre.
• Child abuse in Saudi Arabia: Report of ten cases.
• Childhood immunization in the Kingdom of Saudi Arabia.
• Editorial comment.
• Hydatid cysts in pancreas.
• Migration of central venous catheters.
• Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
• Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
• Nomograms are difficult to beat.
• Predicting Prostate Cancer Behavior-What is a Urologist to Do?
• Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
• Preoperative nomogram predicting 12-year probability of metastatic renal cancer.
• Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
• Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.
• Sarcoma nomogram: validation and a model to evaluate impact of therapy.
• Second colon cancer following Hodgkin's disease. A case report.
• Sitting on the fence in x-ray reporting.
• Systematic review of statistical methods used in molecular marker studies in cancer.
• The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.
• The addition of adrenaline to thoracic epidural meperidine does not improve analgesia following thoracotomy: [L'ajout d'adrenaline a la meperidine peridurale thoracique n'ameliore pas l'analgesie a la suite d'une thoracotomie].
• The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
• The notched articular process of C7 (dorsalization of C7).
• The role of societal benefits and fairness concerns among decision makers and decision recipients.
• Two features of the atlas vertebra simulating fractures by tomography.
• [Not Available.]